Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
03/2003
03/13/2003US20030049813 Extraction of protein or peptide from plant; obtain plant, homogenize, adjust hydrogen ion concentration, heat, centrifuge, suspend pellet, purify protein
03/13/2003US20030049606 Novel anti-viral and anti-proliferative agents derived from STAT1 transcription factor
03/13/2003US20030049605 Display of viral proteins
03/13/2003US20030049604 Viral proteins for use in the treatment and prevention of infection and viral diseases
03/13/2003US20030049600 Kits for use in the detection of virus in sample
03/13/2003US20030049274 PRRSV vaccines
03/13/2003US20030049229 Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes
03/13/2003US20030047518 Process and means to prevent microorganisms blooming in an aquatic system
03/13/2003DE3890874C2 Rekombinante Viren Recombinant viruses
03/13/2003CA2477811A1 Chicken anemia virus vaccine from cell line
03/13/2003CA2458995A1 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof
03/12/2003EP1291434A2 Efficient generation of adenovirus-based libraries by positive selection of adenoviral recombinants through ectopic expression of the adenovirus protease
03/12/2003EP1290205A2 Duplexed parvovirus vectors
03/12/2003EP1290196A1 Chimeric hsf transcription factors
03/12/2003EP1290146A1 Serotype chimeric ibdv strains
03/12/2003EP1290027A2 Immunoadhesin for the prevention of rhinovirus infection
03/12/2003EP1290016A2 Vaccine for congenital tremors in pigs
03/12/2003EP1289547A2 Immunization through oral administration of a vaccine with an edible product
03/12/2003EP1289546A1 Combined preparation for the treatment of neoplasic diseases
03/12/2003CN1402793A Lentiviral triplex DNA, and vectors and recombinant cells contg. same
03/12/2003CN1402792A Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines
03/12/2003CN1402790A DNA encoding plant deoxyhypusine synthase, plant eukaryotic intiation factor 5A, transgenic plants and method for controlling senescence and apoptosis in plants
03/12/2003CN1402780A 感染性克隆 Infectious clone
03/12/2003CN1402615A Irreversible coating particles and compositions contg. these particles
03/12/2003CN1401768A Horse infectious anemia donkey embryo skin cell weak-toxic vaccine strain and culture method thereof
03/12/2003CN1401767A Method for increasing insect virus propagation efficiency
03/11/2003US6531587 Retrovirus from the HIV group and its use
03/11/2003US6531456 Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectors
03/11/2003US6531313 Invasive bacterial vectors for expressing alphavirus replicons
03/11/2003US6531276 Using probes to determine duplex formation; use in diagnostic, prophylactic, and therapeutic applications
03/11/2003US6531137 Retrovirus from the HIV group and its use
03/11/2003US6531135 Administering to the subject an effective amount of a composition comprising a population of infectious, defective alphavirus particles in a pharmaceutically acceptable carrier
03/11/2003US6531123 Safer, yet permit increased efficiency of packaging the recombinant viral genome and increased long-term gene expression
03/10/2003CA2369250A1 Novel anti-viral and anti-proliferative agents derived from stat1 transcription factor
03/06/2003WO2003018820A2 Mutant recombinant adeno-associated viruses related applications
03/06/2003WO2003018785A1 Mutant helper phasge for isolation of antibody molecules in phage display
03/06/2003WO2003018623A2 Papillomavirus proteins and pharmaceutical compositions
03/06/2003WO2003018622A1 Pseudovirions comprising virus capsids, histones and nucleic acids as therapeutic agents
03/06/2003WO2002088327A9 Methods for viral oncoapoptosis in cancer therapy
03/06/2003WO2002078437A3 Novel pesticidal toxins
03/06/2003WO2002074243A9 Methods and compositions for the treatment and/or diagnosis of neurological diseases and disorders
03/06/2003WO2002070651A3 Viral reporter particles
03/06/2003WO2002022080A9 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications
03/06/2003WO2001055393A9 Mhc class ii restricted t cell epitopes from the cancer antigen ny-eso-1
03/06/2003US20030044981 Pseudotyped lentiviral vectors and uses thereof
03/06/2003US20030044963 Generation of adenoviral vectors; provide cell suspension, mix with adenoviral vector, transform cells, propagate recover adenoviral virons
03/06/2003US20030044962 Cell usable in serum-free culture and suspension culture and process for producing virus for vaccine by using the cell
03/06/2003US20030044961 Compositions for transferring active compounds in a cell-specific manner
03/06/2003US20030044960 Picornaviruses, vaccines and diagnostic kits
03/06/2003US20030044937 Nucleotide sequences coding polypeptide for use in the treatment of inflammation and cancer
03/06/2003US20030044773 Genetically engineering viral polypeptide; obtain nucleotide sequences coding polypeptide, insert codon, clone into vector, transform cell, detect expression of genetically engineered polypeptide
03/06/2003US20030044426 Attenuated pestiviruses
03/06/2003US20030044421 Adenoviral vaccines when administered alone or in combined modality regime offer prophylactic advantage to previously uninfected individuals and/or provide therapeutic effect by reducing viral load levels within infected individual
03/06/2003US20030044386 Genetic engineering; nucleic acid coding cytokines
03/06/2003US20030044385 Antitumor, anticancer agents
03/06/2003US20030044384 Treatment of neoplasms with viruses
03/05/2003EP1288304A2 Self-assembled, defective, non-self-propagating viral particles
03/05/2003EP1287152A2 Human-bovine chimeric respiratory syncytial virus vaccines
03/05/2003EP1286694A2 Genetic vaccine that mimics natural viral infection and induces long-lasting immunity to pathogens
03/05/2003CN1400907A 9M-negative EHV-mutants
03/05/2003CN1102659C Recombinant baculovirus insecticides
03/04/2003US6528626 Viral library for use in the diagnosis and treatment of viral diseases
03/04/2003US6528305 Method of producing infectious reovirus
03/04/2003US6528250 Administering multiple low doses of the virus using intravenous route
03/04/2003US6528065 Attenuated dengue-3 virus vaccine
03/04/2003US6528064 Recombinant trytophan mutants of influenza
03/04/2003CA1341423C Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
02/2003
02/27/2003WO2003016540A2 Humanised baculovirus
02/27/2003WO2003016521A2 Aav vector packaging plasmid for producing wtaav particles or pseudotyped aav particles without helper viruses, by means of a single transfection
02/27/2003WO2003016491A2 Retrovirus isolated from mantle histiocytes in mantle cell lymphoma
02/27/2003WO2002086154A8 Methods for generating libraries of therapeutic bacteriophages having desired safety characteristics and methods for labeling and monitoring bacteriophages
02/27/2003WO2002072814A3 Engineered baculoviruses and their use
02/27/2003WO2002066629A8 Recombinant vector containing infectious human cytomegalovirus genome with preserved wild-type characteristics of clinical isolates
02/27/2003WO2002048375A3 Purified active hcv ns2/3 protease
02/27/2003US20030041349 Insect viruses and their uses in protecting plants
02/27/2003US20030040101 Transgenic cell for in the generation and propagation of viral expression vectors
02/27/2003US20030040100 Cell for the propagation of adenoviral vectors
02/27/2003US20030039988 Nucleotide sequences for use as tools in genetic engineering
02/27/2003US20030039955 Compositions and methods for production of RNA viruses and RNA virus-based vector particles
02/27/2003US20030039954 Viral nucleotide sequences for use in the diagnosis, prevention and treatment of viral diseases
02/27/2003US20030039634 Recombinant adenoviruses, use thereof for preparing AAVS, complementary cell line, and pharmaceutical compositions containing said adenoviruses
02/27/2003CA2496542A1 Humanised baculovirus
02/27/2003CA2454879A1 Retrovirus isolated from mantle histiocytes in mantle cell lymphoma
02/26/2003EP1285967A2 Human retroviral packaging cell line
02/26/2003EP1285080A2 Method for the purification of alphavirus replicon particles
02/26/2003EP1285079A2 Modified bovine adenovirus having altered tropism
02/26/2003EP1285078A2 Recombinant aav vectors with aav5 capsids and aav5 vectors pseudotyped in heterologous capsids
02/26/2003CN1398973A Liver cancer targeting hepatitis B antisense RNA expression vector and its construction process and use
02/26/2003CN1398965A Type-O hoof-and-mouth disease virus, type-O hoof-and-mouth disease vaccine with the virus and active component and the prepn of the vaccine
02/26/2003CN1398638A Preparation of tick-borne encephalitis resisting vaccine
02/25/2003US6525179 Methods and compositions for impairing multiplication of HIV-1
02/25/2003US6524853 Model to elucidate the mechanisms of RNA virus replication and the development of RNA virus infections, such as screening for inhibitors of viral growth; hepatitis C virus
02/25/2003US6524821 Anti-apoptotic compositions comprising the R1 subunit of herpes simplex virus ribonucleotide reductase or its N-terminal portion; and uses thereof
02/25/2003US6524588 Influenza vaccine
02/25/2003US6524587 Inoculation of a Dengue fever virus with nil mortality and subsequent injection of irradiated tumor cells derived from the patient. This therapy will safely reduce the tumor burden by 90-99.9%
02/20/2003WO2003014367A1 Method for purification of viral vectors having proteins which bind sialic acid
02/20/2003WO2003014342A2 Identification of a dna variant associated with adult type hypolactasia
02/20/2003WO2003014338A1 Process for producing inactivated virus envelope
02/20/2003WO2003013597A1 Sub-unit vaccine for infectious pancreatic necrosis virus
02/20/2003WO2003000851A3 Method for rapid screening of bacterial transformants and novel simian adenovirus proteins
1 ... 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 ... 267